Literature DB >> 2136711

Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control.

E Bruckert, P Davidoff, A Grimaldi, J Truffert, P Giral, R Doumith, F Thervet, J L De Gennes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2136711

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  20 in total

1.  An application of apo(a) isoforms for the clinical assessment of Lp(a).

Authors:  S Takayama; Y Yasumuro; J h Kim; M Ishikawa; D Tsujino; S Matsuo; Y Harada; S Sugii
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Lp(a) concentrations.

Authors: 
Journal:  BMJ       Date:  1991-11-02

3.  Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population.

Authors:  Lin Ding; An Song; Meng Dai; Min Xu; Wanwan Sun; Baihui Xu; Jichao Sun; Tiange Wang; Yu Xu; Jieli Lu; Weiqing Wang; Yufang Bi; Guang Ning
Journal:  J Lipid Res       Date:  2015-02-03       Impact factor: 5.922

4.  LPA kringle IV type 2 is associated with type 2 diabetes in a Chinese population with very high cardiovascular risk.

Authors:  Di-Li-Da-Er Mu-Han-Ha-Li 迪丽达尔 木汗哈力; Tian-Yu Zhai 翟天羽; Yan Ling 凌雁; Xin Gao 高鑫
Journal:  J Lipid Res       Date:  2018-03-06       Impact factor: 5.922

5.  Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.

Authors:  C Sandholzer; E Boerwinkle; N Saha; M C Tong; G Utermann
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

6.  The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population.

Authors:  Shao-yi Li; Yun Gao; Wei-ning Ma; Hua-chao Wang; Gang Zhou; Wen-chang Guo; Yun-hui Liu
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

7.  Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.

Authors:  J Q Purnell; S M Marcovina; J E Hokanson; H Kennedy; P A Cleary; M W Steffes; J D Brunzell
Journal:  Diabetes       Date:  1995-10       Impact factor: 9.461

8.  Plasma lipids and lipoproteins and essential hypertension.

Authors:  M Flesch; A Sachinidis; Y D Ko; K Kraft; H Vetter
Journal:  Clin Investig       Date:  1994-12

9.  Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.

Authors:  A J Jenkins; J S Steele; E D Janus; J D Santamaria; J D Best
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

10.  Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus.

Authors:  A Császár; H Dieplinger; C Sandholzer; I Karádi; E Juhász; H Drexel; T Halmos; L Romics; J R Patsch; G Utermann
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.